Clinical pharmacy laboratory/4 th Class Anemias and blood disorders

Slides:



Advertisements
Similar presentations
Emcure’s Initiatives in Anemia Management
Advertisements

Adrianna Machelska. Diseases of blood and hematopoietic system are less known but very important part of medical science. We encounter them every day,
Dr. Soban sadiq. Oral Therapy: Ferrous Sulphate Ferrous Fumarate Ferrous Gluconate Parenteral Therapy: Iron Dextran Iron-sucrose complex Iron sodium.
Drug therapy of Anaemias March Anaemia Defined as a reduced number of circulating red blood cells Defined as a reduced number of circulating red.
Anti-Anemia Agents Broyles Chapter 22 Lehmkuhl, 2009.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 55 Anemia Drugs.
CLUES TO THE DIAGNOSIS IN ANEMIA PRINCIPLES 4 Anemia is not a disease 4 There is usually a cause 4 investigation should be logical 4 Start with CBC and.
Agents Used to Treat Anemias. Anemia Decreased number of circulating red blood cells Decreased hemoglobin = decreased oxygen capacity Many causes. 22.
HEMATOPOIETIC AND ANTI- ANEMIA AGENTS February 18, 2014 Thomas M. Guenthner, PhD 407D, MSB
ANEMIA DRUGS DSN KEVIN DOBI, MS, APRN Copyright © 2014 by Mosby, an imprint of Elsevier Inc. Chapter 54.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 55 Drugs for Deficiency Anemias.
Management of Inflammatory bowel disease 8/12/10.
Hydroxocobalamin 1mg/ml Lynne Powell RN, MSc. IP. PgCEd.
بسم الله الرحمن الرحـيـم
AnAemia in Pregnancy Dr. Yasir Katib MBBS, FRCSC Perinatologest.
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
Antianemics Prof. Hanan Hagar
Anemias. Body Contents of Iron Structure of Hemoglobin.
Causes Blood loss – usually from uterus or GI tract Increased demands such as growth and pregnancy Decreased absorption – post gastrectomy, Coeliac disease.
Chapter 22 Agents Used to Treat Anemias. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Anemia.
PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT
Medicine used in the Treatment of Obesity
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
 Stored in the body as ferritin  Deficiency result from negative iron balance due to depletion of stores and/or inadequate intake.  Iron deficiency.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 56 Blood-Forming Drugs.
What is Anemia? Anemia is having less than normal number of red blood cells or less hemoglobin than normal in the blood. *Microcytic Anemia: Any abnormal.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
ANAEMIA IN PREGNANCY AHMED ABDULWAHAB. It is the commonest medical disorder of pregnancy. It is the commonest medical disorder of pregnancy. Physiological.
ERYTHROPOIESIS- STIMULATING AGENTS. Patients who are no longer able to produce enough erythropoietin in the kidneys may benefit from treatment with.
AGENTS FOR MEGALOBLASTIC ANEMIAS. Megaloblastic anemia is treated with folic acid and vitamin B12. Folate deficiencies usually occur secondary to increased.
AGENTS USED FOR IRON DEFICIENCY
Drugs used in Anemia :Lecture outline 1. Definition 2. Types of supplements 3. Clinical pharmacology for each 4. Important indications and adverse effects.
Diagnosis of Megaloblastic Anemia
Chapter 22 Agents Used to Treat Anemias. Anemia p526 Decrease in hemoglobin or decrease in RBCs Many causes of anemia – Iron deficiency anemia – Chemotherapy.
TREATMENT IRON DEFICIENCY ANEMIA. 3 Approaches in the Treatment of IDA: 1.Red Cell Transfusion 2.Oral Iron Therapy 3.Parenteral Iron Therapy Braunwald.
Anemia in Hemodialysis 1. 2 Etiology The anemia of chronic kidney disease (CKD) is primarily due to insufficient production of the glycoprotein hormone.
 A 30 year old male presents to you with complaints of easy fatigability, lack of concentration, breathlessness on performing normal daily activities.
Definition : Anemia is a reduction in the concentration of hemoglobin below normal that results in a reduction of the oxygen-carrying capacity of the blood.
Hematologic Problems Klecka, Spring 2016.
Haematinics These are substances required in the formation of blood, and are used for treatment of anaemias. Anaemia occurs when the balance between production.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
Haematinic Drugs Course: Pharmacology I Course Code: PHR 213 Course Instructor: Ms. Sarah Zaheen Lecturer Department of Pharmacy BRAC University.
Haematinic Drugs Course: Pharmacology I Course Code: PHR 213 Course Instructor: Md. Samiul Alam Rajib Senior Lecturer Department of Pharmacy BRAC University.
The use of Ferinject® (ferric carboxymaltase) in the treatment of iron deficiency in patients with renal anaemia Dr D Farrugia Dr S Ramakrishna E Gibson.
DRUGS USED TO TREAT Anemias Presented by Dr. Sasan Zaeri ParmD, PhD Fall, 2015.
Drugs Used in Anemia.
Cost conscious project: Microcytic anemia
Stomach cancer.
Pharmacology Tutoring for Hematopoietics
Epoetin alfa Drugbank ID : DB00016
Haematological disorders
Hematological System KNH 413.
Folic acid deficiency.
Megaloblastic anemias
Presentation On Routes of drug administration & it’s significance
Claudia Beals, MD John Detesco Erdal Sarac, MD FACP FASN
Effects of Medication Therapeutic Effects=Desired or intended effects of medication – refers to the primary purpose of prescribing and administrating medication.
Controlled drug release
ANAEMIA IN PREGNANCY AHMED ABDULWAHAB.
Methoxy polyethylene glycol-epoetin beta
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Drugs Used in Anemia.
Clinical pharmacy laboratory/4 th Class Anemias and blood disorders
NSAIDs 4th stage students
Drugs Affecting Blood.
PROSES TERAPI DAN PERMASALAHANNYA
Folic acid deficiency.
Haematological disorders
Presentation transcript:

Clinical pharmacy laboratory/4 th Class Anemias and blood disorders Prepared by: Assistant lecturer /Zahraa Abdul- Ghani Assistant lecturer/Lubab Tarek Nafea

Lecture Outlines ORAL IRON:- Ferrous fumarate, ferrous gluconate, ferrous sulphate. PARENTERAL IRON:-iron dextran , iron sucrose , ferric carboxymaltose. Vitamins and trace elements: Folic acid , Vitamin B Preparations :Cyanocobalamin. Erythropoietin (eiopoitins): erythropoietin alfa

Anaemias Initiation of treatment Before initiating treatment for anaemia it is essential to determine which type is present. Iron salts may be harmful and result in iron overload if given to patients with anaemias other than iron deficiency type. Treatment and prophylaxis Treatment with an iron preparation is justified only in the presence of a demonstrable iron-deficiency state. Before starting treatment, it is important to exclude any serious underlying cause of the anaemia (e.g. gastric erosion, gastrointestinal cancer).

Oral iron Iron salts should be given by mouth unless there are good reasons for using another route. Ferrous salts show only marginal differences between one another in efficiency of absorption of iron. Haemoglobin regeneration rate is little affected by the type of salt used provided sufficient iron is given. Choice of preparation is thus usually decided by the incidence of side-effects and cost.

Iron (oral) SIDE-EFFECTS:- Constipation . diarrhoea . epigastric pain (dose related) . faecal impaction . gastro-intestinal irritation . nausea (dose related). MONITORING REQUIREMENTS ▶ Therapeutic response The haemoglobin concentration should rise by about 100–200 mg/ 100mL (1–2 g/litre) per day or 2 g/100mL (20 g/litre) over 3–4 weeks. When the haemoglobin is in the normal range, treatment should be continued for a further 3 months to replenish the iron stores. PRESCRIBING AND DISPENSING INFORMATION ▶ In children Express the dose in terms of elemental iron and iron salt and select the most appropriate preparation. The most common reason for lack of response in children is poor compliance; poor absorption is rare in children. PATIENT AND CARER ADVICE Although iron preparations are best absorbed on an empty stomach they can be taken after food to reduce gastro-intestinal side-effects. May discolour stools.

Ferrous fumarate

Ferrous sulfate

Ferrous gluconate

Parenteral iron :-Iron dextran, iron sucrose, ferric carboxymaltose. Parenteral iron is generally reserved for use when oral therapy is unsuccessful because 1-the patient cannot tolerate oral iron, or 2-becausemalabsorption or 3- in the management of chemotherapy-induced anaemia, or 4- in patients with chronic renal failure who are receiving haemodialysis (and some who are receiving peritoneal dialysis). SIDE-EFFECTS :-Hypersensitivity reactions IMPORTANT SAFETY INFORMATION:- Serious hypersensitivity reactions, including life threatening and fatal anaphylactic reactions, have been reported in patients receiving intravenous iron. These reactions can occur even when a previous administration has been tolerated (including a negative test dose). Test doses are no longer recommended and caution is needed with every dose of intravenous iron. Intravenous iron products should only be administered when appropriately trained staff and resuscitation facilities are immediately available; patients should be closely monitored for signs of hypersensitivity during and for at least 30 minutes after every administration. In the event of a hypersensitivity reaction, treatment should be stopped immediately and appropriate management initiated.

Iron dextran

Iron sucrose

Ferric carboxymaltose

Anaemias , megaloblastic Overview Most megaloblastic anaemias result from a lack of either vitamin B12 or folate. Causes of megaloblastic anaemia : 1.in the UK is pernicious anaemia in which lack of gastric intrinsic factor resulting from an autoimmune gastritis causes malabsorption of vitamin B12. 2.Apart from dietary deficiency, are attributable to malabsorption. Folic acid: Folic acid below has few indications for long-term therapy since most causes of folate deficiency are self-limiting or will yield to a short course of treatment. It should not be used in undiagnosed megaloblastic anaemia unless vitamin B12 is administered concurrently otherwise neuropathy may be precipitated.

Folic acid

vitamin B preparations - Hydroxocobalamin , cyanocobalamin

Erythropoietins Epoetins (recombinant human erythropoietins) Darbepoetin (hyperglycosylated derivative) Methoxy polyethylene glycol-epoetin beta Are used to:- treat the anaemia associated with erythropoietin deficiency in chronic renal failure, to increase the yield of autologous blood in normal individuals and to shorten the period of symptomatic anaemia in patients receiving cytotoxic chemotherapy. Epoetin beta is also used for the prevention of anaemia in preterm neonates of low birth-weight; only unpreserved formulations should be used in neonates because other preparations may contain benzyl alcohol. Darbepoetin alfa is a hyperglycosylated derivative of epoetin; it has a longer half life and can be administered less frequently than epoetin. Methoxy polyethylene glycol-epoetin beta is a continuous erythropoietin receptor activator that is licensed for the treatment of symptomatic anaemia associated with chronic kidney disease. It has a longer duration of action than epoetin.

Thank you